Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.385
-0.035 (-2.46%)
May 1, 2025, 4:00 PM EDT - Market closed

Envoy Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.8-29.92-15.92-8.68
Depreciation & Amortization
0.170.130.080.07
Other Amortization
1.050.6--
Loss (Gain) From Sale of Assets
---0
Stock-Based Compensation
0.561.58--
Other Operating Activities
1.711.57.21.75
Change in Accounts Receivable
0.03-0.030.05-0.02
Change in Inventory
-0.38-0.01-0.190.06
Change in Accounts Payable
-0.020.550.340.23
Change in Other Net Operating Assets
-0.27-1.5-0.36-0.35
Operating Cash Flow
-17.95-17.09-8.81-6.94
Capital Expenditures
-0.98-0.15-0.22-0.13
Investing Cash Flow
-0.98-0.15-0.22-0.13
Long-Term Debt Issued
201088
Long-Term Debt Repaid
-0.92-0.56--
Net Debt Issued (Repaid)
19.089.4488
Issuance of Common Stock
1.750.11--
Preferred Dividends Paid
-2.45---
Dividends Paid
-2.45---
Other Financing Activities
1.8211.740.090.06
Financing Cash Flow
20.221.288.098.06
Foreign Exchange Rate Adjustments
-0.01-0-0.01-0.01
Miscellaneous Cash Flow Adjustments
0---
Net Cash Flow
1.274.04-0.940.99
Free Cash Flow
-18.93-17.24-9.02-7.06
Free Cash Flow Margin
-8412.89%-5456.96%-3807.17%-2277.74%
Free Cash Flow Per Share
-1.01-1.40-0.89-0.70
Levered Free Cash Flow
-12.14-5.91-5.17-
Unlevered Free Cash Flow
-11.63-5.91-5.17-
Change in Net Working Capital
0.4-3.41-0.41-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q